Profile picture

Doctor Fernando Scudiero

Bolognini Hospital, Seriate (Italy)
Follow
Logo ESC

Contributor content

Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity
Presentation
Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity
Hyperthyroidism in Takotsubo syndrome: prevalence, clinical features and long-term outcomes.
Presentation
Hyperthyroidism in Takotsubo syndrome: prevalence, clinical features and long-term outcomes.
Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome
Presentation
Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
Presentation
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome
Presentation
Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome
Relationship between uric acid and contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention: a meta-analysis and meta-regression
Presentation
Relationship between uric acid and contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention: a meta-analysis and meta-regression
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome
Presentation
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome

ESC 365 is supported by